Survival of patients with visceral metastatic melanoma from an occult primary lesion: a retrospective matched cohort study

Annals of Oncology : Official Journal of the European Society for Medical Oncology
G Vijuk, A S Coates

Abstract

Malignant melanoma presents as metastatic disease without an apparent primary in about 4% of cases. These are referred to as occult primary melanoma (OPM). It is not known whether these represent de novo malignant transformation in non-cutaneous sites or the disappearance of an unrecognised primary, perhaps on an immunological basis. We hypothesised that OPM might have a superior prognosis compared to patients with similar disease extent from a known primary lesion (KPM). We performed a retrospective cohort survival study of 146 patients with OPM and visceral metastases treated at the Sydney Melanoma Unit between 1983 and 1996. A control group of patients with KPM was matched for age, sex and site of visceral metastases. Survival was measured from the date of diagnosis of visceral metastases. Patients with OPM had a median survival of 233 days, significantly longer than the 176 days for those with KPM (P = 0.024; logrank test). Multivariate analysis allowing for simultaneous or prior involvement of lymph nodes, subcutaneous tissues or bone, and site of visceral involvement showed a significantly superior survival for OPM (hazard ratio (HR): 0.72; 95% confidence interval (CI): 0.55-0.93). A small part of the effect was explained...Continue Reading

Citations

Feb 24, 2015·Case Reports in Medicine·Sherif Ali EltawansyDavid Sharon
Jun 6, 2003·Oncogene·María S Soengas, Scott W Lowe
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chris C LeeDonald L Morton
Dec 15, 2010·American Journal of Clinical Dermatology·Pascale Quatresooz, Gérald E Piérard
Aug 29, 2000·Psycho-oncology·J E BrownP N Butow
Nov 13, 2012·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Kathryn Skarbez, Lisa Fanciullo
Jul 10, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Krishan ParasharSiyaram Pandey
Jan 9, 2009·Annals of Surgical Oncology·Chris C LeeDonald L Morton
Dec 10, 2008·Journal of Surgical Oncology·Alexandra M EassonDavid R McCready
Mar 25, 2008·The American Journal of Dermatopathology·Patrick O EmanuelRobert G Phelps
Sep 14, 2011·Journal of Gastrointestinal Cancer·Jatinder GoyalEmmanuel S Antonarakis
Mar 7, 2007·Acta chirurgica Iugoslavica·D OpricZ Petrovic
Nov 28, 2018·Journal of Surgical Oncology·Yun Song, Giorgos C Karakousis
May 30, 2020·International Journal of Molecular Sciences·Yu-Jen WuCheng Liu
Aug 6, 2014·Case Reports in Gastrointestinal Medicine·Preethi ReddyBianca Afonso
Jun 30, 2018·Case Reports in Oncological Medicine·Jomjit Chantharasamee, Jitsupa Treetipsatit
Jun 28, 2001·Oncogene·J Mendelsohn, J Baselga
Mar 31, 2012·Medical Oncology·Rita ClericoStefano Calvieri
May 24, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jonathan E DowellWen S Lai
Jan 1, 2021·Critical Reviews in Oncology/hematology·Stergios BoussiosNicholas Pavlidis
Mar 28, 2018·Journal of the American Academy of Dermatology·Jeffrey F ScottJeremy S Bordeaux
Mar 26, 2004·Clinical Radiology·E Kalkman, G Baxter
Jul 20, 2018·Case Reports in Oncology·Mohamad A MouchliLewis Roberts

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Related Papers

Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]
Piotr RutkowskiWlodzimierz Ruka
Archives of Pathology & Laboratory Medicine
Nora V LaverJay S Duker
© 2022 Meta ULC. All rights reserved